ReviewKorean journal of radiology2025
Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions.
Review in Korean journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Comparison of automated breast ultrasound and hand-held breast ultrasound in preoperative evaluation of early-stage breast cancer: a multicenter prospective study.European radiology · 2026Article
- BI-RADS v2025 for breast ultrasound: key updates and Asian perspectives.Ultrasonography (Seoul, Korea) · 2026Article
- Icariin: Multi-target natural products for the multi-stage prevention and treatment of breast cancer (Review).Molecular and clinical oncology · 2026Review
- Trends in Female Breast Cancer Incidence among Japanese, Korean, and US Populations: An Age-Period-Cohort Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Five-Year Breast Cancer Risk Prediction From Screening Breast Ultrasound Using Deep Learning.medRxiv : the preprint server for health sciences · 2026Article
- Rebuilding life after breast cancer treatment among Korean breast cancer survivors: an integrative review.Women's health nursing (Seoul, Korea) · 2026Review
- Artificial Intelligence for Mammography Ready for the Real-World: Turning Promise Into Reality.Korean journal of radiology · 2026Article
- Breast Cancer Screening Programs in China: Implementation, Challenges, and Future Perspectives.Korean journal of radiology · 2026Review
- Beyond mammography: Superior performance of ultrasound in early-onset breast cancer implications for age-specific, density-tailored screening.Turkish journal of surgery · 2026Article
- Validation of the postoperative prognostication tool PREDICT version 2.2 and 3.0 using data from the National cancer center hospital in Japan.Breast cancer (Tokyo, Japan) · 2026Article
- From Standard Establishment to Precision Intelligence: Research Progress in Quality Control of Mammography.Diagnostics (Basel, Switzerland) · 2026Review
- Effect of a Real-Time Artificial Intelligence-Assisted Ultrasound System on BI-RADS C4 Breast Lesions Based on Breast Density.Cancers · 2026Article
- Radiology Research and Publishing Across 2025-2026: Perspectives FromKorean journal of radiology · 2026Article
- Why we still miss breast cancers: strategies for improving mammography interpretation.Insights into imaging · 2026Article
- PAMAM dendrimers as efficient drug nanocarriers of natural compounds in breast cancer therapeutics.Frontiers in oncology · 2026Review
- Screening Outcomes of Supplemental Automated Breast Ultrasound in Women With Nondense Breasts Undergoing Mammography.Korean journal of radiology · 2026Article
- Risk stratification by ultrasound and mammography for screen-detected non-palpable breast cancer in Chinese women.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2022, nearly 2.3 million new cases of breast cancer were reported globally, with less than half of these cases originating from Asia. Despite the relatively low incidence of breast cancer in most parts of Asia, the mortality-to-incidence ratio remains high. Low-income countries lack resources for breast cancer screening, whereas high-income countries fail to fully benefit from national breast screening programs because of the underutilization of preventive healthcare services. There is a notable difference in the age distribution of breast cancer cases between Asian and Western populations, with the prevalence peaking approximately a decade earlier in Asian women and most commonly affecting those aged 40-50 years. Existing literature on breast cancer trends, screening guidelines, and clinical practices in Asian countries, particularly regarding regional variations and healthcare system differences, is relatively sparse. Gaining a deeper understanding of how different Asian countries are implementing breast cancer screening in response to the rising incidence of the disease can help identify tailored strategies for early detection, ultimately contributing to a reduction in breast cancer-related mortality. This review explored the current breast cancer landscape, including breast cancer screening guidelines and outcomes of screening examinations in Asia, highlighting key challenges and future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.